Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer

International Journal of Oncology

Volumn 45, Issue 3, 2014, Pages 1017-1026

  Hasegawa, Masahiro ^a   Maeda, Hiroyuki ^a   Deng, Zeyi ^a,b   Kiyuna, Asanori ^a   Ganaha, Akira ^a   Yamashita, Yukashi ^a   Matayoshi, Sen ^a   Agena, Shinya ^a   Toita, Takafumi ^a   Uehara, Takayuki ^a   Suzuki, Mikio ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Chemoradiotherapy; Human papillomavirus; Oropharyngeal cancer; Planned neck dissection

Indexed keywords

DNA; DOCETAXEL; FLUOROURACIL; NEDAPLATIN; PLATINUM COMPLEX;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHANGE MANAGEMENT; CONCURRENT CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NECK INJURY; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PATIENT RISK; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TIME TO TREATMENT; TREATMENT FAILURE; WART VIRUS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; HUMAN PAPILLOMAVIRUS DNA TEST; LYMPHATIC METASTASIS; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; SURVIVAL; VIROLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FLUOROURACIL; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; ORGANOPLATINUM COMPOUNDS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 84904391564     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2504     Document Type: Article

References (35)

1. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for local advanced head and neck cancer. N Engl J Med 338: 1798-17804, 1998.
2. Argiris A: Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14: 323-329, 2002.
3. Argiris A, Stenson KM, Brockstein BE, et al: Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 26: 447-455, 2004. (Pubitemid 38569204)
4. Kohno N: The role of chemotherapy for advanced oro and hypopharyngeal cancer. Auris Nasus Larynx 31: 113-118, 2004.
5. Brizel DM, Prosnitz RG, Hunter S, et al: Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58: 1418-1423, 2004. (Pubitemid 38438302)
6. Stenson KM, Huo D, Blair E, et al: Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 116: 33-36, 2006. (Pubitemid 44383957)
7. McHam SA, Adelstein DJ, Rybicki LA, et al: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 25: 791-798, 2003. (Pubitemid 37139891)
8. Goenka A, Morris LG, Rao SS, et al: Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer. Int J Cancer 133: 1214-1222, 2013.
9. Hirakawa H, Hasegawa Y, Hanai N, Ozawa T, Hyodo I and Suzuki M: Surgical site infection in clean-contaminated head and neck cancer surgery: risk factors and prognosis. Eur Arch Otorhinolaryngol 270: 1115-1123, 2013.
10. Mendenhall WM, Parsons JT, Cassisi NJ and Million RR: Squamous cell carcinoma of the tonsillar area treated with radical irradiation. Radiother Oncol 10: 23-30, 1987. (Pubitemid 17139703)
11. Suzuki M, Kawakita D, Hani N, et al: The contribution of neck dissection for residual neck disease after chemoradiotherapy in advanced oropharyngeal and hypopharyngeal squamous cell carcinoma patients. Int J Clin Oncol 18: 578-584, 2013.
12. Nouraei SAR, Upile T, Al-Yaghchi C, et al: Role of planned postchemothrapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 118: 797-803, 2008. (Pubitemid 351631295)
13. Narayan K, Crane CH, Kleid S, Hughes PG and Peters LJ: Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 21: 606-613, 1999. (Pubitemid 29459865)
14. Grabenbauer GG, Rödel C, Ernst-Stecken A, et al: Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only? Radiother Oncol 66: 57-63, 2003. (Pubitemid 36136004)
15. Liauw SL, Mancuso AA, Amdur RJ, Morris CG, Villaret DB, Werning JW and Mendenhall WM: Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24: 1421-1427, 2006. (Pubitemid 46622008)
16. Hashibe M, Brennan P, Chuang SC, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 18: 541-550, 2009.
17. Nasman A, Attner P, Hammarstedt L, et al: Incidence of human papillomavirus (hpv) positive tonsillar carcinoma in stockholm, sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125: 362-366, 2009.
18. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35, 2010.
19. Deng Z, Hasegawa M, Matayoshi S, Kiyuna A, Yamashita Y, Maeda H and Suzuki M: Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in okinawa, southern japan. Eur Arch Otorhinolaryngol 268: 1625-1631, 2011.
20. Deng Z, Hasegawa M, Yamashita Y, et al: Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma. Cancer Sci 103: 2127-2134, 2012.
21. Shonka DC Jr, Shoushtari AN, Thomas CY, et al: Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy. Arch Otolaryngol Head Neck Surg 135: 1126-1132, 2009.
22. Huang SH, Patel S, O'Sullivan B, et al: Longer survival in HPV related head and neck cancer patients following positive post radiation planned neck dissection. Head Neck: Mar 14, 2014 (Epub ahead of print). doi: 10.1002/hed.23690.
23. Eisenhauer EA, Therasse P, Bogaerts J, et al: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247, 2009.
24. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ and Snijders PJ: The use of general primers gp5 and gp6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062, 1995.
25. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR and Wolinsky SM: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-214, 1989.
26. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K and Liebert UG: PCR detection of human papillomavirus of the mucosa: comparison between my09/11 and GP5+/6+ primer sets. J Clin Virol 30: 302-308, 2004. (Pubitemid 38649097)
27. Klaes R, Friedrich T, Spitkovsky D, et al: Overexpression of p16(ink4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284, 2001. (Pubitemid 32225381)
28. Singhi AD and Westra WH: Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 116: 2166-2173, 2010.
29. Hillel AT, Fakhry C, Pai S, et al: Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 141: 737-742, 2009.
30. Hinerman RW, Medenhall WM, Amdur RJ, Stringer SP, Villaret DB and Robbins T: Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 24: 456-467, 2002. (Pubitemid 34506706)
31. Davidson BJ, Newkirk KA, Harter W, Picken CA, Cullen KJ and Sessions RB: Complications from planned, posttreatment neck dissections. Neck Surg 125: 401-405, 1999. (Pubitemid 29169766)
32. INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 13: 1355-1360, 2004.
33. INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 44: 133-142, 2008.
34. Thomas J and Primeaux T: Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 16: 91-99, 2012.
35. INK4A as surrogate marker? Cancer Lett 323: 88-96, 2012.